secwatch.observer — SEC 8-K summary
======================================

Issuer:     RADNOSTIX INC (INIS)
CIK:        0001038277
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001515971-22-000039
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 2.01, 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

International Isotopes completes $4M asset sale to Pharmalogic; extends Series C Preferred maturity
--------------------------------------------------------------------------------

- Completed sale of manufacturing equipment and sublease to Pharmalogic Idaho for $4.0M cash on Feb 18, 2022.
- Series C Preferred Stock maturity extended by ~1 year to February 28, 2023, approved by majority of holders.
- Certificate of Amendment filed with Texas Secretary of State on Feb 16, 2022 to reflect the extension.
- The assets sold were acquired via a prior manufacturing and supply agreement termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1038277/000151597122000039/0001515971-22-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1038277/000151597122000039/inis8k022222.htm
  HTML page:      https://secwatch.observer/filing/0001515971-22-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer